scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Eva Szegezdi | Q51081339 |
Bertrand Joseph | Q92361325 | ||
Sanjeev Gupta | Q122928855 | ||
George E N Kass | Q122928872 | ||
P2860 | cites work | Molecular characterization of mitochondrial apoptosis-inducing factor | Q22001452 |
Presence of a pre-apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of jurkat cells | Q22009395 | ||
The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore | Q22011015 | ||
PUMA, a novel proapoptotic gene, is induced by p53 | Q24291463 | ||
A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death | Q24291746 | ||
The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif | Q24291797 | ||
HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins | Q24291802 | ||
Caspase-10 is an initiator caspase in death receptor signaling | Q24291922 | ||
Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain | Q24295878 | ||
Mechanism of XIAP-mediated inhibition of caspase-9 | Q24296916 | ||
Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8. | Q24305298 | ||
Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis | Q24307994 | ||
Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease | Q24309083 | ||
Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis | Q24310597 | ||
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade | Q24311006 | ||
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death | Q24312211 | ||
Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development | Q24317252 | ||
PUMA couples the nuclear and cytoplasmic proapoptotic function of p53 | Q24321694 | ||
The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress | Q24336121 | ||
Caspases: the executioners of apoptosis | Q24530218 | ||
IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases | Q24533214 | ||
Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix | Q24537504 | ||
A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia | Q24561975 | ||
Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors | Q24600405 | ||
Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2 | Q24670800 | ||
Two distinct pathways leading to nuclear apoptosis | Q24676123 | ||
Targeted therapy against Bcl-2-related proteins in breast cancer cells | Q25257509 | ||
Structural and biochemical basis of apoptotic activation by Smac/DIABLO | Q27626899 | ||
Structural basis of IAP recognition by Smac/DIABLO | Q27629148 | ||
Crystal structure of a procaspase-7 zymogen: mechanisms of activation and substrate binding | Q27636119 | ||
The genetics of the p53 pathway, apoptosis and cancer therapy | Q27863460 | ||
A fraction of yeast Cu,Zn-superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria. A physiological role for SOD1 in guarding against mitochondrial oxidative damage. | Q27936872 | ||
The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins | Q28117866 | ||
Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins | Q28117928 | ||
Terminal dUTP nick end labeling (TUNEL) positive cells in the different regions of the brain in normal aging and Alzheimer patients. | Q48735298 | ||
Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus. | Q48766874 | ||
Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice. | Q48975079 | ||
Endonuclease G: a mitochondrial protein released in apoptosis and involved in caspase-independent DNA degradation. | Q49054516 | ||
Ischemic preconditioning depends on interaction between mitochondrial KATP channels and actin cytoskeleton. | Q50519354 | ||
Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. | Q51714635 | ||
Recovery of contractile function of stunned myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane. | Q51766822 | ||
A mitochondrial signal peptide from Neurospora crassa increases the permeability of isolated rat liver mitochondria. | Q52522858 | ||
Oxidative stress, mitochondrial permeability transition and activation of caspases in calcium ionophore A23187-induced death of cultured striatal neurons. | Q52538228 | ||
Purified photoproducts of merocyanine 540 trigger cytochrome C release and caspase 8-dependent apoptosis in human leukemia and melanoma cells. | Q53930758 | ||
Opening of the mitochondrial permeability transition pore by uncoupling or inorganic phosphate in the presence of Ca2+ is dependent on mitochondrial-generated reactive oxygen species. | Q53992783 | ||
Antitumor effect of adenovirus-mediated Bax gene transfer on p53-sensitive and p53-resistant cancer lines. | Q54058131 | ||
bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs | Q54261266 | ||
Intracellular distribution of a platinum-rhodamine 123 complex in cis-platinum sensitive and resistant human squamous carcinoma cell lines. | Q54421868 | ||
Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. | Q55035703 | ||
Light-induced photoactivation of hypericin affects the energy metabolism of human glioma cells by inhibiting hexokinase bound to mitochondria. | Q55477217 | ||
Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore | Q57082833 | ||
Re-examining the role of cytochrome c in cell death | Q57220115 | ||
The mitochondrial permeability transition pore may comprise VDAC molecules | Q58022757 | ||
Phase II clinical trial of arsenic trioxide with liposomal doxorubicin, vincristine, and dexamethasone in newly diagnosed multiple myeloma | Q58049312 | ||
Functional Role of Caspase-1 and Caspase-3 in an ALS Transgenic Mouse Model | Q60144092 | ||
Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis | Q28140307 | ||
Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis | Q28141949 | ||
Interaction of Alzheimer's presenilin-1 and presenilin-2 with Bcl-X(L). A potential role in modulating the threshold of cell death | Q28142036 | ||
TRAIL receptor-2 signals apoptosis through FADD and caspase-8 | Q28142998 | ||
Negative regulation of the Apaf-1 apoptosome by Hsp70 | Q28143100 | ||
Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis | Q28144256 | ||
Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction | Q28199278 | ||
Essential role of voltage-dependent anion channel in various forms of apoptosis in mammalian cells | Q28206500 | ||
Calcium-induced cytochrome c release from CNS mitochondria is associated with the permeability transition and rupture of the outer membrane | Q28208002 | ||
Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice | Q28208193 | ||
Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria | Q28217828 | ||
Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis | Q28240946 | ||
The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore | Q28241418 | ||
Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death | Q28242641 | ||
Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death | Q28242653 | ||
Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3 | Q28246420 | ||
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease | Q28257086 | ||
Regulation of Ca2+-induced permeability transition by Bcl-2 is antagonized by Drpl and hFis1 | Q28261100 | ||
Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases | Q28263484 | ||
Mitochondrial disorders in the nervous system | Q28272320 | ||
From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state | Q28280396 | ||
Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways | Q28289763 | ||
Ligands of the mitochondrial 18 kDa translocator protein attenuate apoptosis of human glioblastoma cells exposed to erucylphosphohomocholine | Q28293859 | ||
Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death | Q28297152 | ||
The mitochondrial permeability transition pore may comprise VDAC molecules. I. Binary structure and voltage dependence of the pore | Q28298388 | ||
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium | Q28304462 | ||
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene | Q28306186 | ||
Viral control of mitochondrial apoptosis | Q28472776 | ||
Apaf1 is required for mitochondrial pathways of apoptosis and brain development | Q28505574 | ||
Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice | Q28507648 | ||
Critical function of endogenous XIAP in regulating caspase activation during sympathetic neuronal apoptosis | Q28510508 | ||
The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues | Q28512628 | ||
Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition | Q28569445 | ||
Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway | Q28581315 | ||
Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study | Q32142109 | ||
Chloromethyl-X-rosamine (MitoTracker Red) photosensitises mitochondria and induces apoptosis in intact human cells. | Q33178571 | ||
Preconditioning protects by inhibiting the mitochondrial permeability transition | Q33201290 | ||
Adenine deoxynucleotides fludarabine and cladribine induce apoptosis in a CD95/Fas receptor, FADD and caspase-8-independent manner by activation of the mitochondrial cell death pathway | Q33208525 | ||
Properties of the permeability transition in VDAC1(-/-) mitochondria | Q33240486 | ||
Resveratrol induces apoptosis through ROS-dependent mitochondria pathway in HT-29 human colorectal carcinoma cells | Q33340077 | ||
Phosphoproteome analysis of isoflurane-protected heart mitochondria: phosphorylation of adenine nucleotide translocator-1 on Tyr194 regulates mitochondrial function. | Q33344170 | ||
Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins | Q33345150 | ||
Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer | Q33436217 | ||
Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study. | Q33501807 | ||
Generation and characterization of endonuclease G null mice | Q33552778 | ||
The in-depth evaluation of suspected mitochondrial disease | Q33608204 | ||
Mitochondrial physiology and pathology; concepts of programmed death of organelles, cells and organisms | Q33811822 | ||
Roles of caspases in apoptosis, development, and cytokine maturation revealed by homozygous gene deficiencies | Q33835849 | ||
TUCAN, an antiapoptotic caspase-associated recruitment domain family protein overexpressed in cancer. | Q33951635 | ||
Plant stress hormones suppress the proliferation and induce apoptosis in human cancer cells | Q34124352 | ||
The harlequin mouse mutation downregulates apoptosis-inducing factor | Q34152182 | ||
Generation and characterization of Smac/DIABLO-deficient mice. | Q34279589 | ||
The mitochondrion in apoptosis: how Pandora's box opens | Q34286386 | ||
A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death | Q34346499 | ||
Reactive oxygen species are downstream mediators of p53-dependent apoptosis | Q34403292 | ||
Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. | Q34406704 | ||
Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide | Q34478428 | ||
Development of ligands for the peripheral benzodiazepine receptor | Q34547615 | ||
Targeted Vpr-derived peptides reach mitochondria to induce apoptosis of alphaVbeta3-expressing endothelial cells | Q34554287 | ||
Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell mitochondria | Q34555806 | ||
Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. | Q34568313 | ||
Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells | Q34615837 | ||
Interaction between cytochrome c and oxidized mitochondrial lipids. | Q34661433 | ||
PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy | Q34670090 | ||
Initiator caspases in apoptosis signaling pathways | Q34724282 | ||
Caspases and apoptosis | Q35015121 | ||
Preservation of mitochondrial function by diazoxide during sustained ischaemia in the rat heart | Q35042002 | ||
The role of immunophilins in mutant superoxide dismutase-1linked familial amyotrophic lateral sclerosis | Q35071074 | ||
Endonuclease G is required for early embryogenesis and normal apoptosis in mice | Q28585337 | ||
Caspases 3 and 7: key mediators of mitochondrial events of apoptosis | Q28588439 | ||
Specific ablation of the apoptotic functions of cytochrome C reveals a differential requirement for cytochrome C and Apaf-1 in apoptosis | Q28589907 | ||
Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of perturbed calcium homeostasis | Q28592853 | ||
BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis | Q28594183 | ||
FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2 | Q28609079 | ||
Mitochondrial Membrane Potential in Living Cells | Q29037927 | ||
Caspases: enemies within | Q29547315 | ||
The BCL-2 protein family: opposing activities that mediate cell death | Q29547380 | ||
An inhibitor of Bcl-2 family proteins induces regression of solid tumours | Q29547595 | ||
The pathophysiology of mitochondrial cell death | Q29547893 | ||
Mitochondrial formation of reactive oxygen species | Q29547906 | ||
Mediators of endoplasmic reticulum stress-induced apoptosis | Q29615496 | ||
Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane | Q29616354 | ||
The Bcl-2 protein family: arbiters of cell survival | Q29618158 | ||
Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9 | Q29618617 | ||
Two CD95 (APO-1/Fas) signaling pathways | Q29619631 | ||
Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics | Q29620467 | ||
Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. | Q30167710 | ||
Isoflurane preconditioning increases B-cell lymphoma-2 expression and reduces cytochrome c release from the mitochondria in the ischemic penumbra of rat brain | Q30439574 | ||
Phosphorylation of BCL-2 regulates ER Ca2+ homeostasis and apoptosis. | Q30554728 | ||
In vitro properties of 5-(benzylsulfonyl)-4-bromo-2-methyl-3(2H)-pyridazinone: a novel permeability transition pore inhibitor | Q30796097 | ||
Targeting the prostate for destruction through a vascular address | Q31037658 | ||
A novel mitochondriotoxic small molecule that selectively inhibits tumor cell growth. | Q31099877 | ||
Kappa- but not delta-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats | Q31723631 | ||
Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3. | Q31929631 | ||
Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore | Q31942254 | ||
Preclinical evaluation of antisense bcl-2 as a chemosensitizer for patients with gastric carcinoma | Q40505607 | ||
Apoptosis-inducing factor determines the chemoresistance of non-small-cell lung carcinomas | Q40529847 | ||
Minimal BH3 peptides promote cell death by antagonizing anti-apoptotic proteins. | Q40663259 | ||
Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization | Q40708852 | ||
Adenovirus-mediated Bax overexpression for the induction of therapeutic apoptosis in prostate cancer. | Q40825681 | ||
Bcl-2 overexpression attenuates dopamine-induced apoptosis in an immortalized neural cell line by suppressing the production of reactive oxygen species | Q40902510 | ||
The novel retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphtalene carboxylic acid can trigger apoptosis through a mitochondrial pathway independent of the nucleus. | Q40907808 | ||
Expression of polyglutamine-expanded Huntingtin activates the SEK1-JNK pathway and induces apoptosis in a hippocampal neuronal cell line | Q41000432 | ||
Differential requirement for caspase 9 in apoptotic pathways in vivo. | Q41015558 | ||
Effects of chronic MPTP and 3-nitropropionic acid in nonhuman primates | Q41143014 | ||
Selective damage to carcinoma mitochondria by the rhodacyanine MKT-077. | Q41235748 | ||
Mitochondrial control of apoptosis | Q41339880 | ||
The p53-deficient mouse: a model for basic and applied cancer studies | Q41436922 | ||
Antisense oligonucleotides as therapeutics for malignant diseases. | Q41454086 | ||
Sensitization for anticancer drug-induced apoptosis by betulinic Acid | Q41468780 | ||
Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury | Q41601375 | ||
Three-dimensional structure of a double apoptosome formed by the Drosophila Apaf-1 related killer | Q41626658 | ||
Caspases: intracellular signaling by proteolysis | Q41656258 | ||
Anti-cancer activity of targeted pro-apoptotic peptides | Q41688099 | ||
Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. | Q41747264 | ||
The release of cytochrome c from mitochondria during apoptosis of NGF-deprived sympathetic neurons is a reversible event | Q41837258 | ||
Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion | Q41977320 | ||
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. | Q42064781 | ||
Pharmacological manipulation of Bcl-2 family members to control cell death | Q42115619 | ||
p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. | Q42125448 | ||
Sequential activation of poly(ADP-ribose) polymerase 1, calpains, and Bax is essential in apoptosis-inducing factor-mediated programmed necrosis. | Q42264580 | ||
Mitochondrial permeability transition during hypothermic to normothermic reperfusion in rat liver demonstrated by the protective effect of cyclosporin A. | Q42264869 | ||
Opening of the mitochondrial permeability transition pore causes matrix expansion and outer membrane rupture in Fas-mediated hepatic apoptosis in mice | Q42484646 | ||
bcl-2 protein is increased in the brain from parkinsonian patients | Q42526032 | ||
Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins | Q42608652 | ||
Bax and Bcl-xL independently regulate apoptotic changes of yeast mitochondria that require VDAC but not adenine nucleotide translocator | Q42633470 | ||
Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice | Q42644118 | ||
Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. | Q42800979 | ||
IAPs are functionally non-equivalent and regulate effector caspases through distinct mechanisms | Q42820922 | ||
Apoptosis induction by the photosensitizer verteporfin: identification of mitochondrial adenine nucleotide translocator as a critical target. | Q43540212 | ||
Cyclosporin A protects hepatocytes against prooxidant-induced cell killing. A study on the role of mitochondrial Ca2+ cycling in cytotoxicity | Q43578822 | ||
Resveratrol, a tumor-suppressive compound from grapes, induces apoptosis via a novel mitochondrial pathway controlled by Bcl-2. | Q43654467 | ||
Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial. | Q43711065 | ||
Deoxyadenosine analogs induce programmed cell death in chronic lymphocytic leukemia cells by damaging the DNA and by directly affecting the mitochondria. | Q43741513 | ||
Mitochondrial ATP-sensitive potassium channels attenuate matrix Ca(2+) overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection | Q43794479 | ||
Paclitaxel affects cytosolic calcium signals by opening the mitochondrial permeability transition pore | Q43810158 | ||
Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437. | Q43830969 | ||
Peripheral benzodiazepine receptor ligands reverse apoptosis resistance of cancer cells in vitro and in vivo. | Q43913554 | ||
Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice | Q43977943 | ||
Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis | Q44028668 | ||
Inhibition of the mitochondrial permeability transition by the nonimmunosuppressive cyclosporin derivative NIM811. | Q44028946 | ||
Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A. | Q44049211 | ||
Mitochondrial permeability transition as a novel principle of hepatorenal toxicity in vivo | Q44122250 | ||
Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ | Q44129457 | ||
Domain-dependent photodamage to Bcl-2. A membrane anchorage region is needed to form the target of phthalocyanine photosensitization | Q44179268 | ||
Halothane, isoflurane and sevoflurane inhibit NADH:ubiquinone oxidoreductase (complex I) of cardiac mitochondria | Q44201713 | ||
All-trans-retinoic acid binds to and inhibits adenine nucleotide translocase and induces mitochondrial permeability transition | Q44253646 | ||
Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart | Q44401253 | ||
Identification of chelerythrine as an inhibitor of BclXL function | Q44408527 | ||
N-terminal deletion augments the cell-death-inducing activity of BAX in adenoviral gene delivery to nonsmall cell lung cancers | Q44429644 | ||
Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme | Q44482659 | ||
Involvement of histone H1.2 in apoptosis induced by DNA double-strand breaks | Q44593627 | ||
Lamellarin D: a novel potent inhibitor of topoisomerase I | Q44652190 | ||
Heat shock protects PC12 cells against MPP+ toxicity | Q44672000 | ||
Minocycline inhibits apoptosis and inflammation in a rat model of ischemic renal injury | Q44917807 | ||
Desensitization of the permeability transition pore by cyclosporin a prevents activation of the mitochondrial apoptotic pathway and liver damage by tumor necrosis factor-alpha | Q44939694 | ||
Mitochondria: releasing power for life and unleashing the machineries of death | Q35071387 | ||
Calcium signaling and apoptosis | Q35120711 | ||
Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase | Q35615453 | ||
Minocycline: neuroprotective mechanisms in Parkinson's disease | Q35668360 | ||
Toxic proteins released from mitochondria in cell death | Q35743127 | ||
Bcl-2 and calcium: controversy beneath the surface | Q35743131 | ||
Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene | Q35884417 | ||
A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak | Q35960931 | ||
Viral proteins targeting mitochondria: controlling cell death | Q35970213 | ||
Death receptor signaling | Q36011453 | ||
Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization | Q36065778 | ||
IAPs, RINGs and ubiquitylation | Q36085601 | ||
Mitochondrial metabolism of reactive oxygen species. | Q36088215 | ||
Targeting antiapoptotic Bcl-2 family members with cell-permeable BH3 peptides induces apoptosis signaling and death in head and neck squamous cell carcinoma cells. | Q36088627 | ||
Killing cancer cells by flipping the Bcl-2/Bax switch. | Q36197245 | ||
The pro-apoptotic proteins, Bid and Bax, cause a limited permeabilization of the mitochondrial outer membrane that is enhanced by cytosol | Q36301514 | ||
Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process | Q36316624 | ||
The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins | Q36400661 | ||
Epsilon protein kinase C as a potential therapeutic target for the ischemic heart | Q36458796 | ||
Regulation of the proapoptotic factor Bax by Ku70-dependent deubiquitylation | Q36516034 | ||
A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. | Q36544465 | ||
Molecular biology of amyotrophic lateral sclerosis: insights from genetics | Q36573336 | ||
Antisense and nonantisense effects of antisense Bcl-2 on multiple roles of Bcl-2 as a chemosensitizer in cancer therapy | Q36623633 | ||
Alzheimer disease: amyloidogenesis, the presenilins and animal models. | Q36701553 | ||
Neuroprotection in traumatic brain injury: a complex struggle against the biology of nature | Q36747114 | ||
Channel formation by antiapoptotic protein Bcl-2. | Q36765713 | ||
The apoptosome: signalling platform of cell death | Q36766418 | ||
p53: guardian of the genome and policeman of the oncogenes. | Q36800812 | ||
Mitochondria-mediated ATP depletion by anti-cancer agents of the jasmonate family | Q36840801 | ||
Conditioning the heart induces formation of signalosomes that interact with mitochondria to open mitoKATP channels | Q36893383 | ||
Viral subversion of apoptotic enzymes: escape from death row. | Q36925632 | ||
The redox environment in the mitochondrial intermembrane space is maintained separately from the cytosol and matrix | Q36944848 | ||
Ischemic preconditioning: from molecular mechanisms to therapeutic opportunities | Q36999938 | ||
The C-terminal tail of presenilin regulates Omi/HtrA2 protease activity | Q45007508 | ||
Mechanisms of acetaminophen-induced hepatotoxicity: role of oxidative stress and mitochondrial permeability transition in freshly isolated mouse hepatocytes | Q45091436 | ||
Caspase-2 permeabilizes the outer mitochondrial membrane and disrupts the binding of cytochrome c to anionic phospholipids | Q45099246 | ||
Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes | Q45108825 | ||
Preconditioning by isoflurane is mediated by reactive oxygen species generated from mitochondrial electron transport chain complex III. | Q45122067 | ||
Hsp27 inhibits 6-hydroxydopamine-induced cytochrome c release and apoptosis in PC12 cells | Q45223075 | ||
Peripheral benzodiazepine receptor (PBR) ligand cytotoxicity unrelated to PBR expression | Q45264559 | ||
DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions | Q45307545 | ||
An adenovirus encoding proapoptotic Bax synergistically radiosensitizes malignant glioma | Q45858863 | ||
Pro-caspase-3 is a major physiologic target of caspase-8. | Q46014432 | ||
The point of no return: mitochondria, caspases, and the commitment to cell death. | Q46018541 | ||
The oxidative inactivation of mitochondrial electron transport chain components and ATPase. | Q46025170 | ||
Ischemic preconditioning: effects on pH, Na and Ca in newborn rabbit hearts during Ischemia/Reperfusion. | Q46030121 | ||
Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness | Q46157086 | ||
Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. | Q46355494 | ||
Resveratrol disrupts peroxynitrite-triggered mitochondrial apoptotic pathway: a role for Bcl-2. | Q46515663 | ||
Benzamide protects delayed neuronal death and behavioural impairment in a mouse model of global cerebral ischemia | Q46576688 | ||
Disruption of the hexokinase-VDAC complex for tumor therapy | Q46602642 | ||
Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice | Q46603535 | ||
Calcium-induced generation of reactive oxygen species in brain mitochondria is mediated by permeability transition | Q46604871 | ||
A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells | Q46619108 | ||
Nicorandil protects cardiac mitochondria against permeability transition induced by ischemia-reperfusion. | Q46642344 | ||
IAPs--the ubiquitin connection | Q46645031 | ||
Methyl jasmonate binds to and detaches mitochondria-bound hexokinase | Q46647628 | ||
The direct physiological effects of mitoK(ATP) opening on heart mitochondria. | Q46688354 | ||
Protective effects of 4-amino1,8-napthalimide, a poly (ADP-ribose) polymerase inhibitor in experimental diabetic neuropathy | Q46762361 | ||
Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta. | Q46775026 | ||
Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes | Q46915798 | ||
Nicotinamide attenuates retinal ischemia and light insults to neurones | Q46919317 | ||
Avicins, a novel plant-derived metabolite lowers energy metabolism in tumor cells by targeting the outer mitochondrial membrane | Q47807867 | ||
PK11195, a ligand of the mitochondrial benzodiazepine receptor, facilitates the induction of apoptosis and reverses Bcl-2-mediated cytoprotection. | Q47935164 | ||
Caspases disrupt mitochondrial membrane barrier function. | Q48025808 | ||
Cyclosporin A significantly ameliorates cortical damage following experimental traumatic brain injury in rodents | Q48091139 | ||
Analyses of energy metabolism and mitochondrial genome in post-mortem brain from patients with Alzheimer's disease | Q48272110 | ||
Cytochrome C is released from mitochondria into the cytosol after cerebral anoxia or ischemia | Q48307610 | ||
Re-evaluation of mitochondrial permeability transition as a primary neuroprotective target of minocycline | Q48386601 | ||
Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. | Q48548442 | ||
Isoflurane preconditioning uncouples mitochondria and protects against hypoxia-reoxygenation. | Q48630672 | ||
Distinct roles for sarcolemmal and mitochondrial adenosine triphosphate-sensitive potassium channels in isoflurane-induced protection against oxidative stress. | Q48685006 | ||
Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage | Q37010881 | ||
BCL-2 family proteins: critical checkpoints of apoptotic cell death | Q37038230 | ||
How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? | Q37100016 | ||
Targeting the Bcl-2-regulated apoptosis pathway by BH3 mimetics: a breakthrough in anticancer therapy? | Q37120213 | ||
Minocycline and N-methyl-4-isoleucine cyclosporin (NIM811) mitigate storage/reperfusion injury after rat liver transplantation through suppression of the mitochondrial permeability transition | Q37130634 | ||
Cytochrome c: functions beyond respiration | Q37196132 | ||
Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments | Q37209427 | ||
Mitochondrial alterations in Parkinson's disease: new clues | Q37235429 | ||
Regulation of hexokinase binding to VDAC | Q37235994 | ||
Update on the pathogenesis of Parkinson's disease | Q37267302 | ||
Bcl-2 inhibitors: small molecules with a big impact on cancer therapy | Q37275477 | ||
The p53 family and programmed cell death | Q37310208 | ||
Metal-catalyzed oxidation of proteins. Physiological consequences | Q37629819 | ||
Hexokinase-binding properties of the mitochondrial VDAC protein: inhibition by DCCD and location of putative DCCD-binding sites | Q38208439 | ||
Inhibition of adenine nucleotide translocator by lipid peroxidation products | Q38564880 | ||
ABT-737 induces expression of the death receptor 5 and sensitizes human cancer cells to TRAIL-induced apoptosis | Q39965483 | ||
Inhibition of apoptosome formation by suppression of Hsp90beta phosphorylation in tyrosine kinase-induced leukemias | Q39966770 | ||
A novel paradigm for rapid ABT-737-induced apoptosis involving outer mitochondrial membrane rupture in primary leukemia and lymphoma cells. | Q40007589 | ||
Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: mapping the site of binding. | Q40007779 | ||
Apoptosis mechanisms related to the increased sensitivity of Jurkat T-cells vs A431 epidermoid cells to photodynamic therapy with the phthalocyanine Pc 4. | Q40020538 | ||
Overcoming chemoresistance of non-small cell lung carcinoma through restoration of an AIF-dependent apoptotic pathway | Q40074076 | ||
Effects of natural and novel synthetic jasmonates in experimental metastatic melanoma | Q40172235 | ||
Cooperative cytotoxicity of methyl jasmonate with anti-cancer drugs and 2-deoxy-D-glucose | Q40204588 | ||
Chelerythrine and sanguinarine dock at distinct sites on BclXL that are not the classic BH3 binding cleft | Q40225582 | ||
Synthetic Smac peptide enhances the effect of etoposide-induced apoptosis in human glioblastoma cell lines | Q40297721 | ||
Cancer cell mitochondria are direct proapoptotic targets for the marine antitumor drug lamellarin D. | Q40304094 | ||
The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases | Q40341729 | ||
Selective proapoptotic activity of a secreted recombinant antibody/AIF fusion protein in carcinomas overexpressing HER2. | Q40355121 | ||
A novel isoform of TUCAN is overexpressed in human cancer tissues and suppresses both caspase-8- and caspase-9-mediated apoptosis | Q40365854 | ||
Bepridil, an antiarrhythmic drug, opens mitochondrial KATP channels, blocks sarcolemmal KATP channels, and confers cardioprotection | Q40370821 | ||
A bifunctional targeted peptide that blocks HER-2 tyrosine kinase and disables mitochondrial function in HER-2-positive carcinoma cells | Q40390361 | ||
Involvement of mitochondrial potential and calcium buffering capacity in minocycline cytoprotective actions | Q40407735 | ||
The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition | Q40421507 | ||
Cyclosporine and liver regeneration studied byin vivo 31P nuclear magnetic resonance spectroscopy | Q64004801 | ||
Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection | Q64382269 | ||
Histochemical detection of apoptosis in Parkinson's disease. | Q67401850 | ||
ABT-737, proving to be a great tool even before it is proven in the clinic | Q67531174 | ||
Protein oxidation and proteolysis during aging and oxidative stress | Q69377246 | ||
Involvement of the bcl-2 gene in human follicular lymphoma | Q69870224 | ||
Protection in the late stages of paracetamol-induced liver cell injury with fructose, cyslosporin A and trifluoperazine | Q71008584 | ||
Cisplatin, epirubicin, and vindesine with or without lonidamine in the treatment of inoperable nonsmall cell lung carcinoma: a multicenter randomized clinical trial | Q71117003 | ||
[Action of the mastoparan from hornet venom on mitochondria] | Q71141854 | ||
The requirement for ferric in the initiation of lipid peroxidation by chelated ferrous iron | Q71701775 | ||
Selective toxicity of rhodamine 123 in carcinoma cells in vitro | Q71727138 | ||
Apoptosis related antigen, Le(Y) and nick-end labeling are positive in spinal motor neurons in amyotrophic lateral sclerosis | Q72382032 | ||
The peptide mastoparan is a potent facilitator of the mitochondrial permeability transition | Q72591996 | ||
Loss of molecular interaction between cytochrome c and cardiolipin due to lipid peroxidation | Q73101546 | ||
Complex I function in familial and sporadic dystonia | Q73282830 | ||
Apoptosis in mitochondrial encephalomyopathies with mitochondrial DNA mutations: a potential pathogenic mechanism | Q73302183 | ||
Ischemic preconditioning in rats: role of mitochondrial K(ATP) channel in preservation of mitochondrial function | Q73377326 | ||
A phase I and pharmacokinetic study of the mitochondrial-specific rhodacyanine dye analog MKT 077 | Q73404027 | ||
DNA laddering and caspase 3-like activity in the spinal cord of a mouse model of familial amyotrophic lateral sclerosis | Q73570352 | ||
Tetrocarcin A inhibits mitochondrial functions of Bcl-2 and suppresses its anti-apoptotic activity | Q73574308 | ||
Overexpression of bax sensitizes breast cancer MCF-7 cells to cisplatin and etoposide | Q73719805 | ||
Distinct pathways for stimulation of cytochrome c release by etoposide | Q74232909 | ||
Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss | Q74495012 | ||
Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2, Bcl-x(L) and Bax oligomerization, induction of cytochrome c release, and activation of cell death | Q74504191 | ||
MKT-077, localized lipophilic cation: antitumor activity against human tumor xenografts serially transplanted into nude mice | Q74619562 | ||
The central executioners of apoptosis: caspases or mitochondria? | Q77135310 | ||
Evidence of a novel event during neuronal death: development of competence-to-die in response to cytoplasmic cytochrome c | Q77531504 | ||
Apoptosis: cell death defined by caspase activation | Q77921203 | ||
ATP-sensitive K+ channel openers prevent Ca2+ overload in rat cardiac mitochondria | Q78157357 | ||
Pretreatment with the cyclosporin derivative, NIM811, improves the function of synaptic mitochondria following spinal cord contusion in rats | Q80170100 | ||
Mitochondria and neurodegeneration | Q80184491 | ||
Membrane-insertion fragments of Bcl-xL, Bax, and Bid | Q80478793 | ||
PHAPI, CAS, and Hsp70 promote apoptosome formation by preventing Apaf-1 aggregation and enhancing nucleotide exchange on Apaf-1 | Q81160686 | ||
A structure of the human apoptosome at 12.8 A resolution provides insights into this cell death platform | Q81446314 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | mitochondrion | Q39572 |
signal transduction | Q828130 | ||
apoptotic process | Q14599311 | ||
mitochondrial membrane potential | Q70709058 | ||
P304 | page(s) | 1004-1033 | |
P577 | publication date | 2009-02-09 | |
2009-06-01 | |||
P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
P1476 | title | The mitochondrial death pathway: a promising therapeutic target in diseases | |
P478 | volume | 13 |
Q53641134 | 17β-estradiol protects against apoptosis induced by interleukin-1β in rat nucleus pulposus cells by down-regulating MMP-3 and MMP-13. |
Q34746484 | A functional yeast survival screen of tumor-derived cDNA libraries designed to identify anti-apoptotic mammalian oncogenes |
Q33980322 | ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2. |
Q34548719 | Ageing is a risk factor in imatinib mesylate cardiotoxicity |
Q39820072 | Alleviation of Lead-Induced Apoptosis by Puerarin via Inhibiting Mitochondrial Permeability Transition Pore Opening in Primary Cultures of Rat Proximal Tubular Cells |
Q91635404 | Anti-inflammatory and Anti-oxidative Effects of Phytohustil® and Root Extract of Althaea officinalis L. on Macrophages in vitro |
Q39069150 | Anticarcinogenic effects of the ethanolic extract of Salix aegyptiaca in colon cancer cells: involvement of Akt/PKB and MAPK pathways. |
Q47132552 | Antitumor effect of Quercetin on Y79 retinoblastoma cells via activation of JNK and p38 MAPK pathways |
Q31040702 | Antitumor peptides from marine organisms |
Q36638317 | Apoptosis Activation in Human Lung Cancer Cell Lines by a Novel Synthetic Peptide Derived from Conus californicus Venom |
Q36645684 | Apoptotic and anti-metastatic effects of the whole skin of Venenum bufonis in A549 human lung cancer cells |
Q53403527 | Attenuation of Aluminum Chloride-Induced Neuroinflammation and Caspase Activation Through the AKT/GSK-3β Pathway by Hesperidin in Wistar Rats. |
Q37673274 | Basic mechanisms of neurodegeneration: a critical update |
Q38859153 | Butein Shows Cytotoxic Effects and Induces Apoptosis in Human Ovarian Cancer Cells |
Q35117885 | Calycosin suppresses breast cancer cell growth via ERβ-dependent regulation of IGF-1R, p38 MAPK and PI3K/Akt pathways |
Q55024479 | Cancer-mitochondria-targeted photodynamic therapy with supramolecular assembly of HA and a water soluble NIR cyanine dye. |
Q38260863 | Cell death controlling complexes and their potential therapeutic role |
Q35129332 | Chemistry and biology of the caged Garcinia xanthones. |
Q38737004 | Comparison of cell cycle components, apoptosis and cytoskeleton-related molecules and therapeutic effects of flavopiridol and geldanamycin on the mouse fibroblast, lung cancer and embryonic stem cells. |
Q48237980 | Cryptotanshinone protects against adriamycin-induced mitochondrial dysfunction in cardiomyocytes |
Q30353924 | Direct Activation of Bax Protein for Cancer Therapy |
Q33814899 | Effect of nitric oxide on mitochondrial activity of human synovial cells. |
Q37696104 | Effective elimination of adult B-lineage acute lymphoblastic leukemia by disulfiram/copper complex in vitro and in vivo in patient-derived xenograft models |
Q42660093 | Effects of 2-chlorodeoxyadenosine (Cladribine) on primary rat microglia |
Q39726293 | Estrogen prevents sustained COLO-205 human colon cancer cell growth by inducing apoptosis, decreasing c-myb protein, and decreasing transcription of the anti-apoptotic protein bcl-2. |
Q37632266 | Expressing and functional analysis of mammalian apoptotic regulators in yeast |
Q36236370 | Garcinia dulcis Fruit Extract Induced Cytotoxicity and Apoptosis in HepG2 Liver Cancer Cell Line. |
Q91588254 | Genetic Aberrations Associated with Photodynamic Therapy in Colorectal Cancer Cells |
Q33750839 | Grifolin induces apoptosis and promotes cell cycle arrest in the A2780 human ovarian cancer cell line via inactivation of the ERK1/2 and Akt pathways |
Q37604361 | HIV-1 promonocytic and lymphoid cell lines: an in vitro model of in vivo mitochondrial and apoptotic lesion. |
Q21145793 | HSP72 protects cells from ER stress-induced apoptosis via enhancement of IRE1alpha-XBP1 signaling through a physical interaction |
Q54365523 | Hydrogen sulfide improves left ventricular function in smoking rats via regulation of apoptosis and autophagy. |
Q39633395 | Hypersensitivity of mtDNA-depleted cells to staurosporine-induced apoptosis: roles of Bcl-2 downregulation and cathepsin B. |
Q39917387 | In silico method for identification of promising anticancer drug targets. |
Q39228259 | Induction of apoptosis by a potent caffeic acid derivative, caffeic acid undecyl ester, is mediated by mitochondrial damage in NALM-6 human B cell leukemia cells |
Q83306849 | Induction of heat shock protein 70 inhibits ischemic renal injury |
Q37448208 | Inhibitory effect of bufalin on retinoblastoma cells (HXO-RB44) via the independent mitochondrial and death receptor pathway |
Q33744850 | LFG-500, a newly synthesized flavonoid, induces apoptosis in human ovarian carcinoma SKOV3 cells with involvement of the reactive oxygen species-mitochondria pathway |
Q33651806 | Mechanisms of ER Stress-Mediated Mitochondrial Membrane Permeabilization |
Q36910181 | Mechanisms of mitochondrial damage in keratinocytes by pemphigus vulgaris antibodies |
Q35738711 | MicroRNA-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and -independent pathways |
Q39168078 | Microarray determination of Bcl-2 family protein inhibition sensitivity in breast cancer cells |
Q40828864 | Mitochondrial permeability transition and its regulatory components are implicated in apoptosis of primary cultures of rat proximal tubular cells exposed to lead |
Q61445001 | Mitochondrial transplantation regulates antitumour activity, chemoresistance and mitochondrial dynamics in breast cancer |
Q35113557 | Molecular mechanisms of 3,3'-dichlorobenzidine-mediated toxicity in HepG2 cells |
Q46616233 | Montelukast, a cysteinyl leukotriene receptor-1 antagonist protects against hippocampal injury induced by transient global cerebral ischemia and reperfusion in rats. |
Q39434576 | Neuroglobin and friends |
Q38811039 | Novel 1,5-diphenyl-6-substituted 1H-pyrazolo[3,4-d]pyrimidin-4(5H)-ones induced apoptosis in RKO colon cancer cells |
Q90745972 | Oligomannuronate prevents mitochondrial dysfunction induced by IAPP in RINm5F islet cells by inhibition of JNK activation and cell apoptosis |
Q37774895 | Oxidative stress and beta-cell dysfunction |
Q36744894 | Pentoxifylline and the proteasome inhibitor MG132 induce apoptosis in human leukemia U937 cells through a decrease in the expression of Bcl-2 and Bcl-XL and phosphorylation of p65. |
Q40695527 | Porphyromonas gingivalis Differentially Modulates Cell Death Profile in Ox-LDL and TNF-α Pre-Treated Endothelial Cells. |
Q36774130 | Procaspase-9 induces its cleavage by transnitrosylating XIAP via the Thioredoxin system during cerebral ischemia-reperfusion in rats |
Q38750384 | Process-relevant concentrations of the leachable bDtBPP impact negatively on CHO cell production characteristics. |
Q54395421 | Production of recombinant proteoliposomes for therapeutic uses. |
Q46247597 | Protective Effects of Hesperidin (Citrus Flavonone) on High Glucose Induced Oxidative Stress and Apoptosis in a Cellular Model for Diabetic Retinopathy |
Q58612028 | Pyronaridine exerts potent cytotoxicity on human breast and hematological cancer cells through induction of apoptosis |
Q39900172 | RTKN2 Induces NF-KappaB Dependent Resistance to Intrinsic Apoptosis in HEK Cells and Regulates BCL-2 Genes in Human CD4(+) Lymphocytes. |
Q43181416 | Rapamycin, an mTOR inhibitor, induced apoptosis via independent mitochondrial and death receptor pathway in retinoblastoma Y79 cell |
Q89511610 | Reconstituting the Mammalian Apoptotic Switch in Yeast |
Q47107025 | Sensitization of neuroblastoma for vincristine-induced apoptosis by Smac mimetic LCL161 is attended by G2 cell cycle arrest but is independent of NFκB, RIP1 and TNF-α. |
Q90581915 | Should we reconsider the apoptosis as a strategic player in tissue regeneration? |
Q35718966 | Sorafenib-induced apoptosis of chronic lymphocytic leukemia cells is associated with downregulation of RAF and myeloid cell leukemia sequence 1 (Mcl-1). |
Q35787581 | TAT Modification of Alpha-Helical Anticancer Peptides to Improve Specificity and Efficacy |
Q44201291 | The mitochondrion is a common target of disease pathophysiology in pemphigus and pemphigoid |
Q38331196 | The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update. |
Q39169079 | The proteasome inhibitor lactacystin exerts its therapeutic effects on glioma via apoptosis: an in vitro and in vivo study |
Q42316616 | Toxoplasma control of host apoptosis: the art of not biting too hard the hand that feeds you. |
Q38853777 | shRNA Depletion of cIAP1 Sensitizes Human Ovarian Cancer Cells to Anticancer Agent-Induced Apoptosis |
Q28387031 | β-elemene effectively suppresses the growth and survival of both platinum-sensitive and -resistant ovarian tumor cells |
Search more.